Quantcast

Posts related to ‘RIGL’

Abbott’s Hep-C Pressures All Hep-C Rivals (ABT, RIGL, GILD, VRTX, IDIX)

News from Abbott Laboratories (NYSE: ABT) on its positive Phase II study results from two different interferon-free hepatitis C treatment has the entire drug sector up in arms as it ...
Read Full Story »
biotech

Rigel’s Troubled Arthritis Treatment

Biotehc firm Rigel's (RIGL) rheumatoid arthritis drug candidate R788 did not meet its primary endpoint in Phase IIb clinical trial, probably putting in question the company’s goal of securing ...
Read Full Story »

Top Day Trader Alerts (RIGL, MSFT, SPWR, ALGN, AMZN, JNPR, ERIC, SEPR)

The following are some of the top stocks to watch for active trading today based on pre-market and after-hours volume activity. There are links through to more detailed coverage and ...
Read Full Story »

Biotech Business Daily (RIGL, BIIB, ARRY, ALNY, FOLD, HALO, AOB, STEM)

Here are some of the top stories affecting key drug and biotech stocks that have links through to more in-depth coverage and analysis today at the website BioHealthInvestor.com: Rigel Pharmaceuticals ...
Read Full Story »
Money Stack Image

Top Day Trader Alerts (AA, CENX, NTAP, DDUP, EMC, RIGL, NVAX, HGSI, CPKI, SCSC)

These are some of the this morning's top day trader alert stocks to watch based on pre-market and after-hours volume activity.  These have links through to more detailed trading and ...
Read Full Story »

Top Pre-Market Analyst Upgrades & Downgrades (EXPO, EHTH, INCY, RIGL, WBD, AMR, AMLN, BKUNA, NGG)

It is getting pretty thin in analyst coverage as we get closer to Labor Day, but these are the upgrades and downgrades we are seeing this Wednesday morning:Exponent (EXPO) Started ...
Read Full Story »

Pre-Market Stock News (November 14, 2007)

Below is some of the top news pre-market:Applied Materials (AMAT) reports earnings after close; estimates are $0.29 EPS & R$2.38B.BEA Systems (BEAS) said it expects to submit SEC filings tomorrow ...
Read Full Story »